{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T11:29:58Z","timestamp":1769167798262,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"S5","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Despite intense investment growth and technology development, there is an observed bottleneck in drug discovery and development over the past decade. NIH started the Molecular Libraries Initiative (MLI) in 2003 to enlarge the pool for potential drug targets, especially from the \u201cundruggable\u201d part of human genome, and potential drug candidates from much broader types of drug-like small molecules. All results are being made publicly available in a web portal called PubChem.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In this paper we construct a network from bioassay data in PubChem, apply network biology concepts to characterize this bioassay network, integrate information from multiple biological databases (e.g. DrugBank, OMIM, and UniHI), and systematically analyze the potential of bioassay targets being new drug targets in the context of complex biological networks. We propose a model to quantitatively prioritize this druggability of bioassay targets, and literature evidence was found to confirm our prioritization of bioassay targets at a roughly 70% accuracy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our analysis provide some measures of the value of the MLI data as a resource for both basic chemical biology research and future therapeutic discovery.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2105-12-s5-s1","type":"journal-article","created":{"date-parts":[[2011,8,9]],"date-time":"2011-08-09T19:14:36Z","timestamp":1312917276000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The BioAssay network and its implications to future therapeutic discovery"],"prefix":"10.1186","volume":"12","author":[{"given":"Jintao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald H","family":"Lushington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Huan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,7,27]]},"reference":[{"issue":"2","key":"4658_CR1","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1377\/hlthaff.25.2.420","volume":"25","author":"CP Adams","year":"2006","unstructured":"Adams CP, Brantner VV: Estimating the cost of new drug development: is it really 802 million dollars? Health Aff (Millwood). 2006, 25(2):420\u2013428. 10.1377\/hlthaff.25.2.420","journal-title":"Health Aff (Millwood)"},{"issue":"10","key":"4658_CR2","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/nbt1338","volume":"25","author":"MA Yildirim","year":"2007","unstructured":"Yildirim MA, Goh KI, Cusick ME, Barab\u00e1si AL, Vidal M: Drug-Target Network. Nat. Biotechnol 2007, 25(10):1119\u20131126. 10.1038\/nbt1338","journal-title":"Nat. Biotechnol"},{"key":"4658_CR3","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1038\/nbt1005-1243","volume":"23","author":"M Cokol","year":"2005","unstructured":"Cokol M, Iossifov I, Weinreb C, Rzhetsky A: Emergent behavior of growing knowledge about molecular interactions. Nat. Biotechnol. 2005, 23: 1243\u20131247. 10.1038\/nbt1005-1243","journal-title":"Nat. Biotechnol"},{"issue":"8","key":"4658_CR4","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/nrd1470","volume":"3","author":"I Kola","year":"2004","unstructured":"Kola I, Landis J: Can the pharmaceutical industry reduce attrition rates? Nat. Rev. Drug Discov. 2004, 3(8):711\u2013716. 10.1038\/nrd1470","journal-title":"Nat. Rev. Drug Discov"},{"issue":"10","key":"4658_CR5","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S1359-6446(97)01099-4","volume":"2","author":"T Kennedy","year":"1997","unstructured":"Kennedy T: Managing the drug discovery\/development interface. Drug Discovery Today 1997, 2(10):436\u2013444. 10.1016\/S1359-6446(97)01099-4","journal-title":"Drug Discovery Today"},{"issue":"2","key":"4658_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S1359-6446(04)03316-1","volume":"10","author":"F Sams-Dodd","year":"2005","unstructured":"Sams-Dodd F: Target-based drug discovery: is something wrong? Drug Discov. Today 2005, 10(2):139\u2013147. 10.1016\/S1359-6446(04)03316-1","journal-title":"Drug Discov. Today"},{"issue":"5699","key":"4658_CR7","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1126\/science.1105511","volume":"306","author":"C Austin","year":"2004","unstructured":"Austin C, Brady L, Insel T, Collins F: NIH Molecular Libraries Initiative. Science 2004, 306(5699):1138\u20131139. 10.1126\/science.1105511","journal-title":"Science"},{"issue":"5642","key":"4658_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1126\/science.1091867","volume":"302","author":"E Zerhouni","year":"2003","unstructured":"Zerhouni E: The NIH Roadmap. Science 2003, 302(5642):63\u201372. 10.1126\/science.1091867","journal-title":"Science"},{"issue":"6","key":"4658_CR9","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.cell.2005.08.029","volume":"122","author":"U Stelzl","year":"2005","unstructured":"Stelzl U, et al.: A Human Protein-Protein Interaction Network: A Resource for Annotating the Proteome. Cell 2005, 122(6):957\u2013968. 10.1016\/j.cell.2005.08.029","journal-title":"Cell"},{"key":"4658_CR10","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gkl817","volume":"35","author":"G Chaurasia","year":"2007","unstructured":"Chaurasia G, Iqbal Y, Hanig C, Herzel H, Wanker EE, Futschik ME: UniHI: an entry gate to the human protein interactome. Nucl. Acids Res. 2007, 35: D590-D594. 10.1093\/nar\/gkl817","journal-title":"Nucl. Acids Res"},{"key":"4658_CR11","doi-asserted-by":"publisher","first-page":"D657","DOI":"10.1093\/nar\/gkn841","volume":"37","author":"G Chaurasia","year":"2009","unstructured":"Chaurasia G, Malhotra S, Russ J, Schnoegl S, Hanig C, Wanker EE, Futschik ME: UniHI 4: new tools for query, analysis and visualization of the human protein-protein interactome. Nucl. Acids Res. 2009, 37: D657\u2013660. 10.1093\/nar\/gkn841","journal-title":"Nucl. Acids Res"},{"key":"4658_CR12","doi-asserted-by":"publisher","first-page":"D668","DOI":"10.1093\/nar\/gkj067","volume":"34","author":"DS Wishart","year":"2006","unstructured":"Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, Chang Z, Woolsey J: DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucl. Acids Res. 2006, 34: D668-D672. 10.1093\/nar\/gkj067","journal-title":"Nucl. Acids Res"},{"key":"4658_CR13","doi-asserted-by":"publisher","first-page":"D901","DOI":"10.1093\/nar\/gkm958","volume":"36","author":"DS Wishart","year":"2008","unstructured":"Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M: DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucl. Acids Res. 2008, 36: D901-D906.","journal-title":"Nucl. Acids Res"},{"key":"4658_CR14","doi-asserted-by":"publisher","first-page":"D514","DOI":"10.1093\/nar\/gki033","volume":"33","author":"A Hamosh","year":"2005","unstructured":"Hamosh A, Scott A, Amberger J, Bocchini C, McKusick V: Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucl. Acids Res. 2005, 33: D514-D5177.","journal-title":"Nucl. Acids Res"},{"issue":"21","key":"4658_CR15","doi-asserted-by":"publisher","first-page":"8685","DOI":"10.1073\/pnas.0701361104","volume":"104","author":"KI Goh","year":"2007","unstructured":"Goh KI, Cusick ME, Valle D, Childs B, Vidal M, Barabasi AL: The human disease network. Proc. Natl. Acad. Sci. 2007, 104(21):8685\u20138690. 10.1073\/pnas.0701361104","journal-title":"Proc. Natl. Acad. Sci"},{"issue":"5439","key":"4658_CR16","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1126\/science.286.5439.509","volume":"286","author":"AL Barabasi","year":"1999","unstructured":"Barabasi AL, Albert R: Emergence of Scaling in Random Networks. Science 1999, 286(5439):509\u2013512. 10.1126\/science.286.5439.509","journal-title":"Science"},{"key":"4658_CR17","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1126\/science.1073374","volume":"297","author":"E Ravasz","year":"2002","unstructured":"Ravasz E, Somera A, Mongru D, Oltvai Z, Barabasi AL: Hierarchical organization of modularity in metabolic networks. Science 2002, 297: 1551\u20131555. 10.1126\/science.1073374","journal-title":"Science"},{"key":"4658_CR18","doi-asserted-by":"publisher","first-page":"D471","DOI":"10.1093\/nar\/gki113","volume":"33","author":"JT Eppig","year":"2005","unstructured":"Eppig JT, Bult CJ, Kadin JA, Richardson JE, Blake JA, Mouse Genome Database Group: The Mouse Genome Database (MGD): from genes to mice-a community resource for mouse biology. Nucl. Acids Res 2005, 33: D471-D475. 10.1093\/nar\/gki498","journal-title":"Nucl. Acids Res"},{"issue":"42","key":"4658_CR19","doi-asserted-by":"publisher","first-page":"30019","DOI":"10.1074\/jbc.274.42.30019","volume":"274","author":"E Petrotchenko","year":"1999","unstructured":"Petrotchenko E, Doerflein M, Kakuta Y, Pedersen L, Negishi M: Substrate Gating Confers Steroid Specificity to Estrogen Sulfotransferase. J. Biol. Chem. 1999, 274(42):30019\u201330022. 10.1074\/jbc.274.42.30019","journal-title":"J. Biol. Chem"},{"key":"4658_CR20","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1038\/sj.onc.1208546","volume":"24","author":"F Wang","year":"2005","unstructured":"Wang F, Zhu Y, Huang Y, McAvoy S, Johnson W, et al.: Transcriptional repression of WEE1 by Kruppel-like factor 2 is involved in DNA damage-induced apoptosis. Oncogene 2005, 24: 3875\u20133885. 10.1038\/sj.onc.1208546","journal-title":"Oncogene"},{"key":"4658_CR21","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nrd747","volume":"1","author":"R Neubig","year":"2002","unstructured":"Neubig R, Siderovski D: Regulators of G-Protein Signalling As New Central Nervous System Drug Targets. Nat. Rev. Drug Discov. 2002, 1: 187\u2013197. 10.1038\/nrd747","journal-title":"Nat. Rev. Drug Discov"},{"key":"4658_CR22","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1213\/01.ANE.0000147711.51122.4B","volume":"100","author":"G Xie","year":"2005","unstructured":"Xie G, Palmer P: RGS Proteins: New Players in the Field of Opioid Signaling and Tolerance Mechanisms. Anesth. Analg. 2005, 100: 1034\u20131042. 10.1213\/01.ANE.0000147711.51122.4B","journal-title":"Anesth. Analg"},{"issue":"4","key":"4658_CR23","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1371\/journal.pbio.0050073","volume":"5","author":"Y Hua","year":"2007","unstructured":"Hua Y, Vickers T, Baker B, Bennett C, Krainer A: Enhancement of SMN2 exon 7 inclusion by antisense oligonucleotides targeting the exon. PLoS Biol 2007, 5(4):e73. 10.1371\/journal.pbio.0050073","journal-title":"PLoS Biol"},{"key":"4658_CR24","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1124\/mol.104.008672","volume":"67","author":"N M","year":"2005","unstructured":"M N, Borlak J: RSK4 and PAK5 Are Novel Candidate Genes in Diabetic Rat Kidney and Brain. Mol. Pharmacol. 2005, 67: 604\u2013611.","journal-title":"Mol. Pharmacol"},{"issue":"2","key":"4658_CR25","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.jmb.2008.12.033","volume":"386","author":"I Westwood","year":"2009","unstructured":"Westwood I, Cheary D, Baxter J, Richards M, van Montfort R, Fry A, Bayliss R: Insights into the Conformational Variability and Regulation of Human Nek2 Kinase. J. Mol. Biol. 2009, 386(2):476\u2013485. 10.1016\/j.jmb.2008.12.033","journal-title":"J. Mol. Biol"},{"issue":"7","key":"4658_CR26","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nn.2346","volume":"12","author":"G Morfini","year":"2009","unstructured":"Morfini G, You Y, Pollema S, Kaminska A, Liu K, et al.: Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin. Nat. Neurosci. 2009, 12(7):864\u2013871. 10.1038\/nn.2346","journal-title":"Nat. Neurosci"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2105-12-S5-S1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T14:35:39Z","timestamp":1630506939000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/1471-2105-12-S5-S1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,27]]},"references-count":26,"journal-issue":{"issue":"S5","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["4658"],"URL":"https:\/\/doi.org\/10.1186\/1471-2105-12-s5-s1","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,27]]},"assertion":[{"value":"27 July 2011","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"S1"}}